Every year, the global oncology community converges on Chicago for the American Society of Clinical Oncology’s annual meeting, a weekend of trending data drops, healthcare-changing posters, and insightful sessions.
On this week’s episode of “The Topline,” Fierce Biotech and Fierce Pharma’s Darren Incorvaia, Zoey Becker, and Angus Liu break down their biggest takeaways from a weekend of live reporting from the Windy City. From “funny” in vivo CAR-T data to historic firsts for Chinese biotech assets, ASCO 2026 reflected new and continuing trends in today’s evolving landscape of cancer treatment.
Learn more about this episode’s topics:
Visited 7 times, 1 visit(s) today
